Lentiviral Gene Therapy for Sickle Cell Disease: Trial Results

by Archynetys Health Desk

“`text
You are a journalist for 🔶 SITE_NAME, a 🔶 NEWS_VERTICAL publication. You are writing a fact-checked,evergreen explainer about 🔶 TOPIC.

Your article will be published on 🔶 PUBLICATION_DATE and should be accurate as of that date. It will be updated regularly. The canonical URL for this article is 🔶 CANONICAL_URL.

Your audience is 🔶 TARGET_AUDIENCE. Write in a tone that is 🔶 TONE.

Your article should include the following sections:
🔶 INTRODUCTION_SECTION
🔶 BODY_SECTIONS
🔶 CONCLUSION_SECTION

Use inline citations for all factual claims. The citation should be a superscript number that corresponds to a numbered list of references at the end of the article.

do not include any facts that is not directly relevant to the topic. Do not include any personal opinions or speculation.

Here are some relevant references:

  • platt, O. S. et al. Mortality in sickle cell disease.Life expectancy and risk factors for early death. N. Engl. J. med. 3301639-1644 (1994).

    Article
    CAS
    PubMed

    Google Scholar

  • Vlachadis, N. & Vrachnis, N. A review of sickle cell disease. JAMA 3281979 (2022).

    Article
    PubMed

    Google scholar

  • Kavanagh, P. L., fasipe, T. A.& Wun, T. sickle cell disease: a review. JAMA 32857-68 (2022).

    Article
    CAS
    PubMed

    Google Scholar

  • Walters, M. C. et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol. Blood Marrow Transplant. 2100-104 (1996).

    CAS
    PubMed

    Google Scholar

  • Townes T. M. Gene replacement therapy for sickle cell disease and other blood disorders. Hematology Am. Soc. Hematol. Educ. Program. https://doi.org/10.1182/asheducation-2008.1.193 (2008).

  • Esrick, E. B. et al. Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. N. Engl. J. Med. 384205-215 (2021).

  • Related Posts

    Leave a Comment